Chronic opioid therapy in long-term cancer survivors (Q38904553)

7 September 2017

1 reference

title

Chronic opioid therapy in long-term cancer survivors (English)

1 reference

7 September 2017

0 references

Alberto Carmona-Bayonas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27443415%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

P Jiménez-Fonseca

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27443415%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

E Castañón

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27443415%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

A Ramchandani-Vaswani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27443415%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

R Sánchez-Bayona

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27443415%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

A Custodio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27443415%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

D Calvo-Temprano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27443415%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

J A Virizuela

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27443415%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

21 July 2016

1 reference

Clinical and Translational Oncology

7 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27443415%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27443415%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27443415%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

236-250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27443415%20AND%20SRC:MED&resulttype=core&format=json

Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Cancer survivors: a booming population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Cancer treatment and survivorship statistics, 2014

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Quality of life among long-term breast cancer survivors: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

21 January 2018

Pain in cancer survivors

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Pain in long-term breast cancer survivors: the role of body mass index, physical activity, and sedentary behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Esophageal resection for cancer of the esophagus: long-term function and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Psychological distress in head and neck cancer patients 7-11 years after curative treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Quality of life of long-term survivors of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

It's Not over When it's Over: Long-Term Symptoms in Cancer Survivors—A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Opioid misuse and abuse: risk assessment and management in patients with cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Screening for substance abuse risk in cancer patients using the Opioid Risk Tool and urine drug screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

μ-Opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Use of opioid analgesics or sleeping medication and survival of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Hypogonadism in men consuming sustained-action oral opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Association Between Serum Cortisol and Testosterone Levels, Opioid Therapy, and Symptom Distress in Patients with Advanced Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Opioid misuse behaviors in adolescents and young adults in a hematology/oncology setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Effects of morphine and its metabolites on immune function in advanced cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Risk stratification of opioid misuse among patients with cancer pain using the SOAPP-SF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Comparative mortality among Department of Veterans Affairs patients prescribed methadone or long-acting morphine for chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Predictors of long-term opioid treatment among patients who receive chemoradiation for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

A single-center, retrospective analysis evaluating the utilization of the opioid risk tool in opioid-treated cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Association of increased postoperative opioid administration with non-small-cell lung cancer recurrence: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Long-Term Chronic Opioid Therapy Discontinuation Rates from the TROUP Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Opioid Analgesics and the Risk of Fractures in Older Adults with Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Chronic use of opioid analgesics in non-malignant pain: report of 38 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Characteristics of older adults receiving opioids in primary care: treatment duration and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Elucidating risk factors for androgen deficiency associated with daily opioid use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Factors associated with early opioid prescription among workers with low back injuries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Effects of postoperative analgesia with the combination of tramadol and lornoxicam on serum inflammatory cytokines in patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Correlation between the administration of morphine or oxycodone and the development of infections in patients with cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Long-term use of narcotic/antidepressant medication in the management of phantom limb pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

The effect of tramadol on serum cytokine response in patients undergoing pulmonary lobectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Association of opioid requirement and cancer pain with survival in advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

μ-Opioid receptor gene (OPRM1) polymorphism in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Quality of life associated with daily opioid therapy in a primary care chronic pain sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Bisphosphonate treatment may reduce osteoporosis risk in female cancer patients with morphine use: a population-based nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Association of intensive morphine treatment and increased stroke incidence in prostate cancer patients: a population-based nested case–control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Modest increase in risk of acute coronary syndrome associated with morphine use in cancer patients: a population-based nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Subdural haemorrhage is associated with recent morphine treatment in patients with cancer: a retrospective population-based nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Opioid use for noncancer pain and risk of myocardial infarction amongst adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Opioids and breast cancer recurrence: A Danish population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Chronic pain, opioid prescriptions, and mortality in Denmark: A population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

A population-based cohort study on chronic pain: the role of opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Mechanisms of opioid-mediated inhibition of human T cell receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Direct effect of morphine on breast cancer cell function in vitro: role of the NET1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Differentiation state affects morphine induced cell regulation in neuroblastoma cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Opioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Methadone, commonly used as maintenance medication for outpatient treatment of opioid dependence, kills leukemia cells and overcomes chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Morphine improved the antitumor effects on MCF-7 cells in combination with 5-Fluorouracil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Morphine modulates cell proliferation through mir133b &mir128 in the neuroblastoma SH-SY5Y cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Opioid-induced chemokine expression requires NF-κB activity: the role of PKCζ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Effects of bombesin on methadone-induced apoptosis of human lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Morphine Modulates Interleukin-4- or Breast Cancer Cell-induced Pro-metastatic Activation of Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

A comparative study of morphine stimulation and biphalin inhibition of human glioblastoma T98G cell proliferation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Secreted PCSK9 promotes LDL receptor degradation independently of proteolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Tramadol and its metabolite m1 selectively suppress transient receptor potential ankyrin 1 activity, but not transient receptor potential vanilloid 1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Effects of morphine and fentanyl on 5-fluorouracil sensitivity in human colon cancer HCT116 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Functional expression of mu-opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Methadone induces CAD degradation and AIF-mediated necrotic-like cell death in neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Small cell carcinoma cell lines contain opioid peptides and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Matrix metalloproteinase 2 secretion in WEHI 164 fibrosarcoma cells is nitric oxide-related and modified by morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Morphine-induced macrophage apoptosis: the role of transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Chronic morphine treatment attenuates cell growth of human BT474 breast cancer cells by rearrangement of the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

beta-arrestin2 inhibits opioid-induced breast cancer cell death through Akt and caspase-8 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Activation of μ opioid receptors modulates inflammation in acute experimental colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Evaluation of osteoporosis risk associated with chronic use of morphine, fentanyl and tramadol in adult female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Morphine suppresses tumor angiogenesis through a HIF-1alpha/p38MAPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Morphine inhibits migration of tumor-infiltrating leukocytes and suppresses angiogenesis associated with tumor growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Morphine induces splenocyte apoptosis and enhanced mRNA expression of cathepsin-B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Morphine and clonidine combination therapy improves therapeutic window in mice: synergy in antinociceptive but not in sedative or cardiovascular effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Liver and kidney toxicity in chronic use of opioids: an experimental long term treatment model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses. A pilot randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Efficacy of opioids for chronic pain: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

ISSLS prize winner: early predictors of chronic work disability: a prospective, population-based study of workers with back injuries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Opioids in chronic non-cancer pain: systematic review of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Opioid therapy for nonspecific low back pain and the outcome of chronic work loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Effects of opioids on the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

21 January 2018

Opiates and infection

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Modulation of immune function by morphine: implications for susceptibility to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Effects of opioids on immunologic parameters that are relevant to anti-tumour immune potential in patients with cancer: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Risk of a Second Kidney Carcinoma Following Childhood Cancer: Role of Chemotherapy and Radiation Dose to Kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Second Primary Lung Cancer After Head and Neck Cancer: Implications for Screening Computed Tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Endocrine complications in long-term survivors of childhood cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Evolution of vertebrate opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Narcotic-induced hypogonadism during therapy for heroin addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

The impact of opioids on the endocrine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

The unsolved case of "bone-impairing analgesics": the endocrine effects of opioids on bone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Coronary heart disease outcomes among chronic opioid and cyclooxygenase‐2 users compared with a general population cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

The comparative safety of analgesics in older adults with arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Chronic opioid use and central sleep apnea: a review of the prevalence, mechanisms, and perioperative considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Long-term opioid therapy reconsidered

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Who gets high-dose opioid therapy for chronic non-cancer pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Pain medication use among patients with posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Linking "big" personality traits to anxiety, depressive, and substance use disorders: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Cancer survivors and unemployment: a meta-analysis and meta-regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Employment and work-related issues in cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Opioid treatment of chronic pain in patients with addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Long- or short-acting opioids for chronic non-malignant pain? A qualitative systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

The epidemiology of herpes zoster in patients with newly diagnosed cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Bisphosphonate associated osteonecrosis of the jaw.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Pelvic insufficiency fracture after pelvic radiotherapy for cervical cancer: analysis of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Upper-extremity pain disorders in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Sexual function in females after radiotherapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Second Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-016-1529-6

Management of arthralgias associated with aromatase inhibitor therapy

21 January 2018

1 reference

12 December 2020

Exogenous morphine inhibits human gastric cancer MGC- 803 cell growth by cell cycle arrest and apoptosis induction.

1 reference

12 December 2020

Prospective study evaluating the plasma concentrations of twenty-six cytokines and response to morphine treatment in cancer patients

1 reference

12 December 2020

Drug Abuse, Dependence, and Addiction in Chronic Pain Patients

1 reference

12 December 2020

Patterns of narcotic drug use in a cancer pain clinic

1 reference

12 December 2020

Treatment of cancer pain: Spanish Society of Medical Oncology (SEOM) recommendations for clinical practice

1 reference

12 December 2020

Chemotherapy-induced peripheral neuropathy

1 reference

12 December 2020

Incidence of shoulder pain after neck dissection: a clinical explorative study for risk factors

1 reference

12 December 2020

Effects of heroin and methadone on plasma cortisol and testosterone

1 reference

12 December 2020

Universal precautions in pain medicine: a rational approach to the treatment of chronic pain

1 reference

12 December 2020

Chronic pain in cancer survivors: a growing issue

1 reference

12 December 2020

Coping strategies of long-term cancer survivors.

1 reference

12 December 2020

The response to analgesia testing is affected by gonadal steroids in the rat

1 reference

12 December 2020

G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation

1 reference

12 December 2020

Opioid agonist--tachykinin antagonist as a new analgesic with adjuvant anticancer properties.

1 reference

12 December 2020

Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma

1 reference

12 December 2020

Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study

1 reference

12 December 2020

Adrenal corticosteroid therapy in far-advanced cancer.

1 reference

12 December 2020

Long-term cause-specific mortality among survivors of childhood cancer

1 reference

12 December 2020

Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial

1 reference

12 December 2020

Endocrine consequences of long-term intrathecal administration of opioids

1 reference

12 December 2020

Avascular osteonecrosis after allogeneic hematopoietic stem-cell transplantation: diagnosis and gender matter

1 reference

12 December 2020

Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival

1 reference

12 December 2020

Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome.

1 reference

12 December 2020

Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries

1 reference

12 December 2020

Effects of testosterone treatment on bone mineral density in hypogonadal men receiving intrathecal opioids

1 reference

12 December 2020

Rates of adverse events of long-acting opioids in a state Medicaid program

1 reference

12 December 2020

What have we learned from three decades of methadone maintenance treatment?

1 reference

12 December 2020

Opioid analgesic-induced apoptosis and caspase-independent cell death in human lung carcinoma A549 cells.

1 reference

12 December 2020

In vivo and in vitro inhibition of human liver cancer progress by downregulation of the μ-opioid receptor and relevant mechanisms

1 reference

12 December 2020

Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor kappaB transcriptional activation in neuroblastoma SH-SY5Y cells

1 reference

12 December 2020

10.1007/S12094-016-1529-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27443415%20AND%20SRC:MED&resulttype=core&format=json

release_ppwtt4ukvfbl7luyaaq2mvhirq

11 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ppwtt4ukvfbl7luyaaq2mvhirq

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27443415%20AND%20SRC:MED&resulttype=core&format=json